Safety and Efficacy of Bone Marrow–Derived Mesenchymal Stem Cells for Chronic Patellar Tendinopathy (With Gap >3 mm) in Patients: 12-Month Follow-up Results of a Phase 1/2 Clinical Trial

Background: In a previous study, the authors found that at 6 months after treatment with a 20 × 10 6 dose of bone marrow–derived mesenchymal stem cells (BM-MSCs), patients showed improved tendon structure and regeneration of the gap area when compared with treatment using leukocyte-poor platelet-ric...

Полное описание

Библиографические подробности

Главные авторы:	Robert Soler MS, MD, Gil Rodas MS, MD, PhD, Joan Rius-Tarruella MD, MBA, Xavier Alomar MS, MD, Ramon Balius MS, MD, PhD, Ángel Ruíz-Cotorro MS, MD, Lorenzo Masci MS, MD, PhD, Nicola Maffulli MS, MD, PhD, Lluís Orozco MS, MD, PhD
Формат:	Artigo
Язык:	Inglês
Опубликовано:	SAGE Publishing 2023-09-01
Серии:	Orthopaedic Journal of Sports Medicine
Online-ссылка:	https://doi.org/10.1177/23259671231184400
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!